SEC Tracker
Get the app

WORK Medical Technology Group WOK

WORK Medical Technology Group FY 2024: net loss $3.5M; diluted EPS −$0.27

Form
20-F
Filed
Period
Importance
Notable
Document
20-F

Key figures from this report

These are the numbers WORK Medical Technology Group reported for the year ended Sep 30, 2024, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Net income−$3.5MNo year-earlier figure tagged20-F income statement, on EDGAR
  2. Diluted EPS−$0.27No year-earlier figure tagged20-F income statement, on EDGAR
  3. Cash and cash equivalents$6.6MNo year-earlier figure tagged20-F balance sheet, on EDGAR
  4. Cash from operations−$2.2MNo year-earlier figure tagged20-F cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when WORK Medical Technology Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.